18,618 followers
Current progress and future perspectives of neoadjuvant anti-PD-1/PD-L1 therapy for colorectal cancer: Immunotherapies, especially the programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) inhibitors, have… #immunology https://t.co/MD9QnjSIjA